Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced major reductions in its outstanding Series C and Series D preferred ...

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

Windtree Therapeutics secures $520M funding to expand its BNB Treasury, committing nearly $700M to digital asset reserves ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced two major equity financing agreements totaling up to ...

Windtree BNB strategy allocates $520M into BNB, marking a bold move in corporate treasury management and sparking mixed ...

Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...